ARQT - Arcutis Biotherapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ARQT (1787306)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
54 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-09-03
ARQTWelgus Howard G.DirS - Sale$10.77-10,000191,944-5%-$107,695
2024-08-19
ARQTBurnett PatrickSee RemarksS - Sale$8.29-1,728194,859-1%-$14,318
2024-08-02
ARQTMatsuda MasaruSee RemarksS - Sale$9.02-5,220183,288-3%-$47,064
2024-08-02
ARQTBurnett PatrickSee RemarksS - Sale$9.02-13,206196,587-6%-$119,106
2024-08-02
ARQTWatanabe Todd FranklinSee RemarksS - Sale$9.02-14,4871,077,403-1%-$130,648
D
2024-08-01
ARQTWelgus Howard G.DirS - Sale+OE$9.87-10,000201,944-5%-$98,696
D
2024-07-01
ARQTWelgus Howard G.DirS - Sale+OE$9.31-10,000205,330-5%-$93,141
D
2024-06-04
ARQTWelgus Howard G.DirS - Sale+OE$8.01-10,000195,191-5%-$80,092
DM
2024-05-29
ARQTBurnett PatrickSee RemarksS - Sale+OE$8.73-72,952209,793-26%-$636,706
2024-05-28
ARQTMatsuda MasaruSee RemarkS - Sale$9.01-1,775188,508-1%-$15,988
2024-05-17
ARQTEdwards Larry ToddSVP Chief Commercial OfficerS - Sale$8.98-7,640140,360-5%-$68,582
2024-05-02
ARQTMoore Matthew RichardSVP, Chief Business OfficerS - Sale$8.74-4,681145,505-3%-$40,902
2024-05-02
ARQTWatanabe Todd FranklinSee RemarksS - Sale$8.74-13,7831,091,890-1%-$120,433
2024-05-02
ARQTMatsuda MasaruSee RemarkS - Sale$8.74-5,016185,408-3%-$43,829
2024-05-02
ARQTBurnett PatrickSee RemarksS - Sale$8.74-9,555259,745-4%-$83,490
2024-03-04
ARQTMatsuda MasaruSee RemarkS - Sale$11.12-3,760190,424-2%-$41,816
2024-03-04
ARQTBurnett PatrickSee RemarksS - Sale$11.12-4,782269,300-2%-$53,182
2024-03-04
ARQTWatanabe Todd FranklinSee RemarksS - Sale$11.12-14,9031,105,673-1%-$165,739
2024-03-04
ARQTMoore Matthew RichardSVP, Chief Business OfficerS - Sale$11.12-3,468146,020-2%-$38,568
2024-03-04
ARQTHeron Patrick JDirP - Purchase$9.50+21,0528,817,6660%+$199,994
2024-02-28
ARQTWatanabe Todd FranklinSee RemarksS - Sale$10.60-2,4651,120,5760%-$26,129
2024-01-02
ARQTBurnett PatrickSee RemarksS - Sale$3.54-1,32557,032-2%-$4,692
D
2023-05-31
ARQTWatanabe Todd FranklinSee RemarksP - Purchase$6.38+1,463733,1590%+$9,334
2023-11-21
ARQTMatsuda MasaruSee RemarkS - Sale$1.98-1,85046,634-4%-$3,661
2023-10-24
ARQTFrazier Life Sciences Viii, L.P.10%P - Purchase$2.50+80,0008,827,261+1%+$200,000
2023-08-21
ARQTBurnett PatrickSee RemarksS - Sale$7.04-1,60558,357-3%-$11,302
2023-05-31
ARQTMatsuda MasaruSee RemarkS - Sale$7.80-1,83043,609-4%-$14,278
D
2023-04-17
ARQTWelgus Howard G.DirS - Sale+OE$13.97-8,500190,816-4%-$118,728
D
2023-04-06
ARQTWelgus Howard G.DirS - Sale+OE$12.01-8,500190,816-4%-$102,085
2023-03-06
ARQTWatanabe Todd FranklinSee RemarksS - Sale$15.26-2,435584,6710%-$37,167
2023-03-06
ARQTBurrows Scott LCFOS - Sale$15.26-29159,1150%-$4,442
2023-03-06
ARQTBurnett PatrickSee RemarksS - Sale$15.26-85159,962-1%-$12,989
2023-03-06
ARQTTurney Patricia A.SVP, OperationsS - Sale$15.26-83162,862-1%-$12,684
2023-03-06
ARQTOsborne David WChief Technical OfficerS - Sale$15.26-690268,8540%-$10,532
2023-03-06
ARQTLock Kenneth A.Chief Commercial OfficerS - Sale$15.26-83163,429-1%-$12,684
D
2023-03-02
ARQTMoore Matthew RichardSee RemarksS - Sale+OE$15.83-1,61026,590-6%-$25,481
D
2023-03-02
ARQTMatsuda MasaruSee RemarksS - Sale+OE$15.83-1,43439,101-4%-$22,696
D
2023-03-02
ARQTBurnett PatrickSee RemarksS - Sale+OE$15.83-1,75160,813-3%-$27,713
M
2023-02-28
ARQTTurney Patricia A.SVP, OperationsS - Sale$15.96-2,36845,693-5%-$37,796
M
2023-02-28
ARQTWatanabe Todd FranklinSee RemarksS - Sale$15.93-7,815587,106-1%-$124,483
M
2023-02-28
ARQTBurrows Scott LCFOS - Sale$15.90-1,85038,406-5%-$29,421
M
2023-02-28
ARQTLock Kenneth A.Chief Commercial OfficerS - Sale$15.96-2,36843,260-5%-$37,796
M
2023-02-28
ARQTOsborne David WChief Technical OfficerS - Sale$15.96-2,005254,644-1%-$32,002
D
2023-02-15
ARQTWelgus Howard G.DirS - Sale+OE$16.98-8,500190,816-4%-$144,352
M
2023-02-13
ARQTWatanabe Todd FranklinSee RemarksS - Sale$17.01-1,000594,9210%-$17,012
2023-02-01
ARQTWatanabe Todd FranklinSee RemarksS - Sale$17.00-1,000595,9210%-$17,003
D
2023-01-17
ARQTWelgus Howard G.DirS - Sale+OE$13.72-8,500190,816-4%-$116,655
2023-01-03
ARQTBurnett PatrickSee RemarksS - Sale$15.01-1,47541,564-3%-$22,136
2022-12-07
ARQTWatanabe Todd FranklinSee RemarksS - Sale$17.06-1,000596,9210%-$17,060
2022-11-21
ARQTMatsuda MasaruSee RemarkS - Sale$18.19-1,72019,535-8%-$31,289
D
2022-11-15
ARQTWelgus Howard G.DirS - Sale+OE$20.01-3,403190,816-2%-$68,103
2022-11-07
ARQTWatanabe Todd FranklinSee RemarksS - Sale$18.00-1,000597,9210%-$18,004
2022-10-07
ARQTWatanabe Todd FranklinPres, CEOS - Sale$19.51-1,000598,9210%-$19,510
2022-10-04
ARQTWelgus Howard G.DirS - Sale$20.29-6,000193,199-3%-$121,766

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top